Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Young adults can benefit from starting retirement planning early. Discover the best retirement plans tailored for your age group.
25,196 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
An 8% jump can feel exciting, but a smart investor asks: what’s next? This guide breaks down how to assess a sudden m...
When a prominent fund makes a sizable stake reduction, it often signals more than profit-taking. This article breaks ...
Dreaming of owning a sports team? This guide explains how everyday investors can participate in the sports ecosystem,...
The race to commercialize solid-state batteries is accelerating, and QuantumScape sits at the center. This deep dive ...
A dramatic 41% weekly jump has investors buzzing about Infleqtion. Learn what fueled the move, how to evaluate quantu...
Costco reports stronger quarterly results as its $250 billion expansion strategy accelerates, supported by a robust m...
Abra aims to go public on Nasdaq through a SPAC valued at about $750 million. This move blends traditional markets wi...
Oasis Management revealed a sizable new stake in Vail Resorts, boosting its position by 237,162 shares in Q1. This ar...
Tilray’s stock has fallen dramatically this year. This in-depth guide breaks down what’s driving the drop, whether th...
Three heavyweight asset managers have pulled back sharply on private credit fears. This piece explains why these fina...
The EV market is shifting quickly, and two growth stocks sit at opposite ends of the spectrum: Tesla and Rivian. This...